Complete Decongestive Therapy (CDT)
Quick Definition: What is Complete Decongestive Therapy (CDT)?
A comprehensive, multi-phase clinical program combining MLD, short-stretch compression bandaging, decongestive exercises, and skin care.
Clinical Overview & Pathophysiology
Complete Decongestive Therapy (CDT) is the primary therapy used worldwide to manage and reduce moderate-to-severe lymphedema. The therapy is divided into two phases. Phase I (the intensive/reductive phase) involves daily clinical visits where MLD is performed, followed by the application of multi-layered, short-stretch compression wraps to prevent refilling. Phase II (the maintenance phase) empowers the patient through self-care, transitioning them to daytime flat-knit compression sleeves, nightly wrapping, self-drainage, and meticulous skin checks to avoid bacterial cellulitis.
Common Indicators & Symptoms
- Phase I: Dynamic reduction of limb volume and tissue softening
- Phase II: Safe, long-term stabilization using specialized compression garments
- Meticulous skin hygiene protocols to eliminate fungal and bacterial entry vectors
- Active decongestive exercises while wrapped to leverage the muscle-pump mechanism
The Four Pillars of CDT
CDT is only effective when all four components are integrated: (1) Manual Lymphatic Drainage, (2) Multi-layered short-stretch compression wrapping, (3) Targeted active movement, and (4) Strict dermatological care to protect skin barrier function.
Clinical References & Research Citations
In alignment with our clinical care framework, this guide is referenced against external, peer-reviewed medical publications: